Elena Christofides, MD, discusses her recent analysis of patients with ulcerative colitis receiving corticosteroids.
Elena A. Christofides, MD
Advertisement
Elena Christofides, MD, is the chief executive officer of Endocrinology Associates, the scientific and medical advisor for Sparrow Pharmaceuticals, and a clinical associate professor at the Ohio University Heritage College of Osteopathic Medicine.
Articles by Elena A. Christofides, MD
Elena Christofides, MD, discusses the interim results of CAPTAIN-T2D, a trial that plans to evaluate clofutriben’s efficacy in these patients.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on HCPLive
1
How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD
2
Counseling Patients On Exa-cel Gene Therapy Journey, With Haydar Frangoul, MD, MS
3
Q&A: How Is Risankizumab’s FDA Approval Changing the Psoriatic Disease Landscape?
4
New Nonsteroidal Options Are Reshaping Pediatric Atopic Dermatitis Care
5